Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurofibromatosis 1 × Vitamin D × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 2 Obesity 2 Vitamin D Deficiency 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Kidney Neoplasms 1 Helicobacter Infections 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

AZD 6244 9 trametinib 3 Lovastatin 3 mirdametinib 2 Sirolimus 2 Inhalation 2 Everolimus 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 pirfenidone 1 peginterferon alfa-2b 1 omipalisib 1 fludarabine 1 cediranib 1 binimetinib 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Sunitinib 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Photochemotherapy 1 Methotrexate 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡